Ester Aso

Has grant

Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ester Aso is an Associate Professor at Universitat de Barcelona, Spain. Her research focuses on the interplay between cannabinoid receptors, dopamine dynamics, and neurodegeneration, particularly in relation to Alzheimer's disease and Parkinson's disease. Recent articles by Professor Aso explore the effects of cannabinoids on neurotransmitter dynamics and address chronic pain through innovative approaches in animal models.

Recent Grants

Grant: Close

Vulnerabilidad a los efectos psicóticos del THC durante la adolescencia: implicación de la interacción entre los receptores CB1, A2A y D2.

Open Date: 2021-01-01

Close Date: 2023-12-01

Grant: Close

EL COMPLEJO TRANS-SINAPTICO FORMADO POR CB1-A2A Y MGLU5 EN EL HIPOCAMPO COMO SUSTRATO DE LOS EFECTOS TERAPEUTICOS DE LOS CANNABINOIDES EN LA ENFERMEDAD DE ALZHEIMER

Open Date: 2019-01-01

Close Date: 2021-12-01

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (17)

Victor Fernandez Dueñas

Profesor Agregado

University of Barcelona

SPAIN

Ester Aso

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Long-lasting behavioral, molecular and functional connectivity alterations after chronic THC exposure during adolescence in mice.

Striatal dopamine D2, adenosine A2A and cannabinoid CB1 receptors balance as a target against non-cognitive symptoms in a mouse model of Alzheimer's disease.

Nanoarchitecture of Ca<sub>V</sub>2.1 channels and GABA<sub>B</sub> receptors in the mouse hippocampus: Impact of APP/PS1 pathology

A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease

Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone

Dopamine dynamics in chronic pain: music-induced, sex-dependent, behavioral effects in mice.

GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rate.

Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects

Cannabidiol negatively modulates adenosine A&lt;sub&gt;2A&lt;/sub&gt; receptor functioning in living cells

Nanoscale alterations in GABAB receptors and GIRK channel organization on the hippocampus of APP/PS1 mice

Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

Impact of the legalisation of recreational cannabis use

Overcoming the Challenges of Detecting GPCR Oligomerization in the Brain

Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia

Synchrotron X-ray Fluorescence and FTIR Signatures for Amyloid Fibrillary and Nonfibrillary Plaques

In situ identification and G4-PPI-His-Mal-dendrimer-induced reduction of early-stage amyloid aggregates in Alzheimer's disease transgenic mice using synchrotron-based infrared imaging

Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6

Collaborators (17)

Victor Fernandez Dueñas

Jesús Giraldo

Dolors Puigoriol Illamola

Anna Castañé

Carolina Aguado

Raimon Sabate

Carmine Ostacolo

Nuria Benseny-Cases

Manuela Bartolini

Concepció Soler

Luis de la Ossa

Yugo Fukazawa

Alba Espargaró

Emanuela Salviati

Kristoffer Sahlholm

Jordi Hernando

Veronica Brito

Make your next move.

Cannabidiol negatively modulates adenosine A<sub>2A</sub> receptor functioning in living cells